Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
Earnings Data
Report Date
Apr 24, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.49Last Year’s EPS
-0.51Same Quarter Last Year
Strong Buy
Based on 11 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 25, 2025
|% Change Since: -18.31%
|Next Earnings Date:Apr 24, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, successful product launches, and progress in prostate cancer treatment initiatives. However, it also acknowledged challenges such as a significant saline supply disruption affecting procedure volumes and higher-than-expected operating expenses.Company Guidance
During the PROCEPT BioRobotics Fourth Quarter and Year End 2024 Earnings Conference Call, the company provided comprehensive guidance for 2025, highlighting expectations for total revenue to reach approximately $320 million, a growth of 43% compared to 2024. They anticipate selling around 210 new robotic systems, with average selling prices ranging from $430,000 to $440,000. The company expects to sell approximately 52,500 handpieces at an average selling price of $3,200. International revenue is projected to grow by 36% to $32.5 million, driven by momentum in the UK and Japan. Gross margins for 2025 are anticipated to be about 64.5%, reflecting a 400 basis point improvement over 2024. Operating expenses are expected to be approximately $300 million, up 28% from the previous year, with a significant portion attributed to noncash stock-based compensation. Overall, the company is focused on leveraging strong commercial execution, expanding its installed base, and advancing its prostate cancer initiatives to drive long-term growth.Significant Revenue Growth
Total revenue for the fourth quarter of 2024 was $68.2 million, representing growth of 57% compared to the fourth quarter of 2023. The full year revenue was $224.5 million, marking a growth of 65%.
Successful HYDROS Robotic System Launch
Received FDA 510(k) clearance for the HYDROS Robotic System, which saw a positive market reception and exceeded expectations. HYDROS accounted for 95% of the 60 systems sold in Q4, with an average selling price of approximately $460,000.
Prostate Cancer Initiative Progress
Successfully demonstrated that Aquablation therapy does not spread cancer cells, leading to FDA lifting the contraindication for patients with prostate cancer. Initiated a pivotal randomized study for prostate cancer with FDA-IDE approval.
International Revenue Surge
International revenue in the fourth quarter was $7.8 million, representing growth of 137% compared to the prior year period, driven by strong sales in the UK.
Record Gross Margin
Achieved a record gross margin of 64% in Q4 2024, an improvement due to operational efficiencies and higher HYDROS System selling prices.
---
PRCT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PRCT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 25, 2025 | $62.71 | $68.11 | +8.61% |
| Oct 28, 2024 | $68.77 | $91.00 | +32.33% |
| Aug 01, 2024 | $62.00 | $57.38 | -7.45% |
| May 01, 2024 | $52.98 | $60.61 | +14.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does PROCEPT BioRobotics (PRCT) report earnings?
PROCEPT BioRobotics (PRCT) is schdueled to report earning on Apr 24, 2025, TBA Not Confirmed.
What is PROCEPT BioRobotics (PRCT) earnings time?
PROCEPT BioRobotics (PRCT) earnings time is at Apr 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRCT EPS forecast?
PRCT EPS forecast for the fiscal quarter 2025 (Q1) is -0.49.
---